MSCI Stock Analysis: 23% Upside Case for 2026 – Institutional Research Note
MSCI stock analysis is the starting point for any serious investor evaluating the financial data infrastructure sector. MSCI Inc. (NYSE: MSCI) occupies one of…
Sector
Technology
Equity research on software, semiconductors and internet platforms. Technology carries the widest gap between reported earnings and durable cash generation, so analysis here concentrates on stock-based compensation, capitalised development costs, customer concentration and whether a moat survives the next platform shift rather than only the current one.
NICE Stock Analysis: 79% Upside Case for 2026 – Institutional Research Note
Executive Summary — Bottom Line Up Front This NICE stock analysis identifies one of the most compelling asymmetric risk/reward setups in enterprise software today.…
Adyen Stock Analysis: 28% Upside Case for 2026 – Institutional Research Note
This Adyen stock analysis examines one of Europe’s most debated fintech names following a sharp 20% single-session selloff on February 12, 2026. Moschovakis Capital’s…
Meituan Stock Analysis: 55% Decline Exposes Critical Risk for 2026 – Institutional Research Note
This Meituan stock analysis examines one of the most dramatic collapses in Chinese internet equities during 2025. Meituan (03690.HK), the dominant on-demand services platform…
Intuit Stock Analysis: 33% Upside Case for 2026 – Institutional Research Note
This Intuit stock analysis identifies one of the most compelling asymmetric opportunities in application software today. INTU trades at $420 — a 50% drawdown…
Tencent Stock Analysis: 24% Upside Case for 2026 – Institutional Research Note
Tencent stock analysis is at the forefront of institutional conviction in Chinese technology for 2026. At Moschovakis Capital, our proprietary equity research framework has…
LSEG Stock Analysis: 44% Upside Case for 2026 – Institutional Research Note
This LSEG stock analysis examines London Stock Exchange Group plc (LON: LSEG) following a severe AI-fear-driven selloff that has created what our proprietary Wealth…
SMCI Stock Analysis: 10 Disqualifying Factors Exposed for 2026 – Institutional Research Note
This SMCI stock analysis represents a comprehensive institutional equity research note published by the Moschovakis Capital Wealth Preservation Research Division. Our mandate is capital…
Doximity Stock Analysis: 70% Upside Case for 2026 – Institutional Research Note
This Doximity stock analysis identifies what we consider one of the most compelling risk-adjusted opportunities in healthcare technology today. At $33.50 per share, DOCS…
QCOM Stock Analysis: 24% Upside Potential for 2026 – Institutional Research Note
Executive Summary QCOM stock analysis reveals one of the most compelling asymmetric opportunities in the semiconductor sector for 2026. This research note examines Qualcomm…